What one share of BioVie holds
There is emerging scientific consensus that both inflammation and insulin resistance may play
BioVie’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$3.05 |
|---|---|
| Cash and investments | $1.19 |
| Book value | $1.36 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$96.25 | — | — | — | $52.50 |
| 2022 | — | −$105.77 | — | — | — | $14.69 |
| 2023 | — | −$154.71 | — | — | — | $42.11 |
| 2024 | — | −$73.05 | — | — | — | $25.05 |
| 2025 | — | −$11.87 | — | — | — | $9.93 |
| 2026 | — | −$3.05 | — | — | — | $1.36 |
Common questions about BioVie
How much does one share of BioVie earn?
Over its latest fiscal year, BioVie lost $3.05 for each share.
Does BioVie pay a dividend?
BioVie didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is BioVie’s book value per share?
BioVie’s book value is $1.36 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of BioVie have?
Each share of BioVie has $1.19 of cash and investments, as of June 30, 2026.
Has BioVie bought back shares?
BioVie’s share count rose about 28432% from 2019 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.